We are live on ! Find out more
AIM

Arcadia Investment Management Portfolio holdings

AUM $584M
1-Year Est. Return 21.44%
This Fund
S&P 500
This Quarter Est. Return
+10.35%
1 Year Est. Return
+21.44%
3 Year Est. Return
+83.48%
5 Year Est. Return
+113.71%
10 Year Est. Return
+434.1%
AUM
$565M
AUM Growth
+$42.1M
Cap. Flow
-$2.06M
Cap. Flow %
-0.36%
Top 10 Hldgs %
37.22%
Holding
341
New
23
Increased
52
Reduced
104
Closed
29

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.56M
2
PEP icon
PepsiCo
PEP
+$1.42M
3
TT icon
Trane Technologies
TT
+$1.18M
4
AVGO icon
Broadcom
AVGO
+$1.17M
5
TSCO icon
Tractor Supply
TSCO
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 36.21%
2 Healthcare 13.53%
3 Consumer Discretionary 10.22%
4 Industrials 8.96%
5 Financials 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NDAQ icon
326
Nasdaq
NDAQ
$53.1B
-10,512
Closed -$611K
NHI icon
327
National Health Investors
NHI
$3.39B
-1
Closed -$29
SCHB icon
328
Schwab US Broad Market ETF
SCHB
$44.7B
-36
Closed -$669
SHEL icon
329
Shell
SHEL
$250B
-984
Closed -$64.7K
SLYG icon
330
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.2B
-150
Closed -$12.5K
STT icon
331
State Street
STT
$51.4B
-4,000
Closed -$310K
TYL icon
332
Tyler Technologies
TYL
$13.2B
-250
Closed -$105K
USA icon
333
Liberty All-Star Equity Fund
USA
$1.87B
-200
Closed -$1.28K
VRTX icon
334
Vertex Pharmaceuticals
VRTX
$134B
-221
Closed -$89.9K
WBA
335
DELISTED
Walgreens Boots Alliance
WBA
-7,267
Closed -$190K
WBD icon
336
Warner Bros
WBD
$67.9B
-2
Closed -$23
AXNX
337
DELISTED
Axonics, Inc. Common Stock
AXNX
-995
Closed -$61.9K
ETRN
338
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
-10,000
Closed -$102K
RPT
339
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
-1,200
Closed -$15.4K

Similar funds

Arcadia Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, Arcadia Investment Management held 341 positions worth $565M, up 8% from $523M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Arcadia Investment Management's Q1 2024 filing shows 23 new, 52 increased, 104 reduced and 29 closed positions. Its largest new stake was Dyne Therapeutics: 31,325 shares worth $889K. The largest sale was Bristol-Myers Squibb, an estimated $1.56M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Arcadia Investment Management's largest Q1 2024 buy was Dyne Therapeutics: 31,325 shares worth $889K.
  • Arcadia Investment Management added most to Mobileye in Q1 2024, an estimated $2.8M increase.
  • Arcadia Investment Management's biggest Q1 2024 reduction was Bristol-Myers Squibb, cutting an estimated $1.56M.
  • Arcadia Investment Management fully exited East-West Bancorp in Q1 2024, selling an estimated $737K.
  • Arcadia Investment Management's ten largest holdings make up 37% of its $565M portfolio in Q1 2024.
  • Arcadia Investment Management opened 23 new positions and closed 29 in Q1 2024.
  • Arcadia Investment Management's portfolio value rose 8% quarter-over-quarter to $565M.

Based on Arcadia Investment Management's 13F filing for Q1 2024, filed 23 Apr 2024.